Southwestern In Vivo Cellular and Molecular Imaging Program

Development Project 1 Novel strategies for therapeutic vascular targeting agents: Lead development investigators: Philip Thorpe, Ph.D. and Sophia Ran, Ph.D. (Pharmacology)

Development Project 2 Diagnostic Imaging to Evaluate Inhibition of the NF-kB Pathway on Growth of Colon Carcinoma: Lead development investigator: Richard Gaynor, M.D. (Internal Medicine)

Development Project 3 Novel and Integrated Approach to Clinical Assessment of Brain Tumor Development and Response to Therapy. Lead development investigator: Karen Fink, M. D., Ph.D. (Neuro Oncology)

Development Project 4 Assessment of the efficacy of novel adenovirus-based gene therapy in urogenital cancers Lead development investigator: J. T. Hsieh, Ph.D. (Urology)

Development Project 5 Imaging Mouse Tumors to Evaluate Treatment by Blocking Negative Signals to NK Cell Lead development investigator: Michael Bennett, M.D. (Pathology)

Development Project 6 In vivo assessment of anti telomerase Peptide Nucleic Acids as a novel cancer therapeutic strategy. Lead development investigator: David Corey, Ph.D. (Biochemistry)

For Further Information Contact: RALPH  P. MASON, Ph.D.
Page Maintained by: Lan Jiang, M.Sc.
Page Created by: Robert Bollinger II
Copyright ©2001 UT Southwestern
Last Updated: